BRAIN Biotech AG (FRA:BNN)

BRAIN Biotech AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 17, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	49	46	93	96	221	141
Market Cap Growth	-1.77%	-50.00%	-3.85%	-56.34%	56.48%	-34.81%
Enterprise Value	38	35	89	83	213	122
Last Close Price	2.19	2.00	4.22	4.47	9.92	6.94
PS Ratio	0.90	0.84	1.65	1.92	5.63	3.61
PB Ratio	7.86	3.34	4.03	2.81	5.28	5.39
P/TBV Ratio	7.86	-	14.13	7.48	8.74	18.77
EV/Sales Ratio	0.71	0.62	1.58	1.65	5.44	3.13
Debt / Equity Ratio	-	1.89	0.45	0.31	0.27	0.50
Asset Turnover	0.73	0.70	0.76	0.65	0.52	0.56
Inventory Turnover	-	2.60	2.66	2.72	2.49	2.33
Quick Ratio	0.84	1.41	0.87	0.93	2.78	2.05
Current Ratio	2.39	1.83	1.46	1.42	3.45	2.68
Return on Equity (ROE)	-98.79%	-60.16%	-28.34%	-16.67%	-13.77%	-38.94%
Return on Assets (ROA)	-7.18%	-7.06%	-4.67%	-5.12%	-6.16%	-6.13%
Return on Capital (ROIC)	-44.37%	-15.30%	-8.86%	-8.12%	-9.99%	-12.69%
Earnings Yield	-24.11%	-24.02%	-8.94%	-6.84%	-2.25%	-6.87%
FCF Yield	-19.08%	-11.09%	-7.38%	-7.56%	-2.34%	-5.38%
Buyback Yield / Dilution	-	-	-	-9.55%	-6.89%	-3.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.